Arnold Library

Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane.

James, Scott E and Greenberg, Philip D and Jensen, Michael C and Lin, Yukang and Wang, Jinjuan and Till, Brian G and Raubitschek, Andrew A and Forman, Stephen J and Press, Oliver W (2008) Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane. Journal of immunology (Baltimore, Md. : 1950), 180 (10). pp. 7028-7038. ISSN 0022-1767

Full text not available from this repository.
Article URL: http://www.jimmunol.org/cgi/content/full/180/10/70...

Abstract

We have targeted CD22 as a novel tumor-associated Ag for recognition by human CTL genetically modified to express chimeric TCR (cTCR) recognizing this surface molecule. CD22-specific cTCR targeting different epitopes of the CD22 molecule promoted efficient lysis of target cells expressing high levels of CD22 with a maximum lytic potential that appeared to decrease as the distance of the target epitope from the target cell membrane increased. Targeting membrane-distal CD22 epitopes with cTCR(+) CTL revealed defects in both degranulation and lytic granule targeting. CD22-specific cTCR(+) CTL exhibited lower levels of maximum lysis and lower Ag sensitivity than CTL targeting CD20, which has a shorter extracellular domain than CD22. This diminished sensitivity was not a result of reduced avidity of Ag engagement, but instead reflected weaker signaling per triggered cTCR molecule when targeting membrane-distal epitopes of CD22. Both of these parameters were restored by targeting a ligand expressing the same epitope, but constructed as a truncated CD22 molecule to approximate the length of a TCR:peptide-MHC complex. The reduced sensitivity of CD22-specific cTCR(+) CTL for Ag-induced triggering of effector functions has potential therapeutic applications, because such cells selectively lysed B cell lymphoma lines expressing high levels of CD22, but demonstrated minimal activity against autologous normal B cells, which express lower levels of CD22. Thus, our results demonstrate that cTCR signal strength, and consequently Ag sensitivity, can be modulated by differential choice of target epitopes with respect to distance from the cell membrane, allowing discrimination between targets with disparate Ag density.

Item Type: Article or Abstract
Additional Information: This article is available to subscribers only via the URL above
PubMed ID: 18453625
NIHMSID: NIHMS42763
PMCID: PMC2585549
Grant Numbers: R21 CA117131, R01 CA76287, CA18029, CA33084.
Keywords or MeSH Headings: Antigens, Neoplasm/immunology; CD8-Positive T-Lymphocytes/immunology; Cell Line, Tumor; Cell Membrane/chemistry; Cytotoxicity, Immunologic; Epitopes, T-Lymphocyte/chemistry/immunology; Flow Cytometry; Humans; Immunotherapy/methods; Leukemia, B-Cell/therapy; Lymphoma, B-Cell/therapy; Receptors, Antigen, T-Cell/chemistry/genetics/immunology;
Subjects: Therapeutics > Biological Therapy > Immunotherapy
Diseases > Hematologic and lymphatic diseases
Molecules > Antigens
Molecules > Proteins > Receptors
Depositing User: Library Staff
Date Deposited: 03 Apr 2009 18:54
Last Modified: 09 Jan 2017 16:42
URI: http://authors.fhcrc.org/id/eprint/86

Repository Administrators Only

View Item View Item
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024
Seattle, WA 98109

a 501(c)(3) nonprofit organization.

© Terms of Use & Privacy Policy